tiprankstipranks
Advertisement
Advertisement

Avalon GloboCare Joins AMD AI Developer Program

Story Highlights
  • Avalon GloboCare was accepted into AMD’s AI Developer Program, gaining access to powerful cloud-based compute, tools, and training for AI development.
  • The company plans to use AMD’s resources to scale Avalon Quantum AI’s automated media and enterprise automation platforms, reinforcing its strategic shift toward AI technologies.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Avalon GloboCare Joins AMD AI Developer Program

Claim 30% Off TipRanks

An update from Avalon GloboCare ( (ALBT) ) is now available.

On February 26, 2026, Avalon GloboCare said it had been accepted into Advanced Micro Devices’ AI Developer Program, giving it access to AMD Developer Cloud credits, high-performance compute resources, tools, and training to support AI development. The program is expected to enhance model training efficiency, inference speed, and scalability for large language and multimodal systems used by Avalon Quantum AI, the subsidiary driving Avalon’s automated commentary video, documentation, and workflow automation platforms.

Avalon plans to use these AMD resources to scale its AI-driven media infrastructure, including automated, evidence-constrained commentary video generation, AI-assisted drafting for public company communications, and enterprise-grade compliance and workflow automation. Management framed the move as reinforcing Avalon Quantum AI’s technical capabilities and supporting the company’s ongoing strategic repositioning as a technology-focused AI player in media production and enterprise applications, potentially strengthening its competitive position in next-generation AI content and automation markets.

More about Avalon GloboCare

Avalon GloboCare Corp. is a technology-focused company developing and acquiring innovative artificial intelligence platforms, with a core emphasis on automated video generation, enterprise documentation, and workflow automation through its AI-driven subsidiary Avalon Quantum AI LLC. The company also maintains an intellectual property portfolio in cellular therapy and generative AI publishing and software, and markets the KetoAir breathalyzer, a U.S. FDA-registered Class I medical device for which it plans additional diagnostic applications.

Average Trading Volume: 281,934

Technical Sentiment Signal: Sell

Current Market Cap: $2.28M

Learn more about ALBT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1